A citation-based method for searching scientific literature

Mark Lebwohl, Andrew Blauvelt, Carle Paul, Howard Sofen, Jolanta Węgłowska, Vincent Piguet, Daniel Burge, Robert Rolleri, Janice Drew, Luke Peterson, Matthias Augustin. J Am Acad Dermatol 2018
Times Cited: 70



J-H Saurat, G Stingl, L Dubertret, K Papp, R G Langley, J-P Ortonne, K Unnebrink, M Kaul, A Camez. Br J Dermatol 2008
Times Cited: 522




List of shared articles



Times cited

Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis.
Craig L Leonardi, Kyoungah See, Russel Burge, Zhuoer Sun, Ying Zhang, Lotus Mallbris, Alyssa Garrelts, Richard B Warren. Adv Ther 2022
0

Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis.
Kyle Fahrbach, Grammati Sarri, David M Phillippo, Binod Neupane, Samantha E Martel, Sandeep Kiri, Kristian Reich. Dermatol Ther (Heidelb) 2021
3

Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method.
U Mrowietz, R B Warren, C L Leonardi, D Saure, H Petto, S Hartz, M Dossenbach, K Reich. J Eur Acad Dermatol Venereol 2021
4

State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis.
Paolo Gisondi, Davide Geat, Miriam Pizzolato, Giampiero Girolomoni. Curr Opin Pharmacol 2019
18

New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies.
Di Yan, Andrew Blauvelt, Amit K Dey, Rachel S Golpanian, Samuel T Hwang, Nehal N Mehta, Bridget Myers, Zhen-Rui Shi, Gil Yosipovitch, Stacie Bell,[...]. J Invest Dermatol 2021
4

Choosing the right biologic for complications of inflammatory bowel disease.
Shana Rakowsky, Konstantinos Papamichael, Adam S Cheifetz. Expert Rev Gastroenterol Hepatol 2022
0

Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data.
Neil H Shear, Keith A Betts, Ahmed M Soliman, Avani Joshi, Yan Wang, Jing Zhao, Paolo Gisondi, Ranjeeta Sinvhal, April W Armstrong. J Am Acad Dermatol 2021
4

Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response.
Laura M Sawyer, Kinga Malottki, Celia Sabry-Grant, Najeeda Yasmeen, Emily Wright, Anne Sohrt, Emma Borg, Richard B Warren. PLoS One 2019
67


Psoriasis in moderate grave plaque - immunobiological treatment.
Marcelo Arnone, André Vicente Esteves de Carvalho, Maria Denise Fonseca Takahashi, Wanderley M Bernardo. Rev Assoc Med Bras (1992) 2019
0

Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.
Nicholas D Brownstone, Quinn G Thibodeaux, Vidhatha D Reddy, Bridget A Myers, Stephanie Y Chan, Tina Bhutani, Wilson Liao. Dermatol Ther (Heidelb) 2020
21

Comparative efficacy and safety of biologics in moderate to severe plaque psoriasis: a multiple-treatments meta-analysis.
Shanshan Xu, Xing Gao, Jixiang Deng, Jiajia Yang, Faming Pan. J Dtsch Dermatol Ges 2021
3

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.
Richard B Warren, Kyoungah See, Russel Burge, Ying Zhang, Alan Brnabic, Gaia Gallo, Alyssa Garrelts, Alexander Egeberg. Dermatol Ther (Heidelb) 2020
17


Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis.
April W Armstrong, Luis Puig, Avani Joshi, Martha Skup, David Williams, Junlong Li, Keith A Betts, Matthias Augustin. JAMA Dermatol 2020
65

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach, Laurence Le Cleach. Cochrane Database Syst Rev 2022
0

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach, Laurence Le Cleach. Cochrane Database Syst Rev 2021
14


Biologics for chronic inflammatory skin diseases: an update for the clinician.
Yiqiu Yao, Astrid-Helene Ravn Jørgensen, Simon Francis Thomsen. J Dermatolog Treat 2020
8

How current biologic therapies affect the risk of major adverse cardiovascular events in patients with plaque psoriasis? A systematic review and meta-analysis of randomized controlled trials.
Sonia Nartowicz, Ewelina Jakielska, Monika Priadka, Zygmunt Adamski, Piotr Ratajczak, Krzysztof Kus. Postepy Dermatol Alergol 2020
1

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Sivem Afach, Liz Doney, Corinna Dressler, Camille Hua, Canelle Mazaud, Céline Phan, Carolyn Hughes, Dru Riddle,[...]. Cochrane Database Syst Rev 2020
69

Representation of older adults in randomized controlled trials on systemic treatment in plaque psoriasis: A systematic review.
Mirjam J Schaap, Marieke E C van Winden, Marieke M B Seyger, Elke M G J de Jong, Satish F K Lubeek. J Am Acad Dermatol 2020
2

Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis.
April W Armstrong, Ahmed M Soliman, Keith A Betts, Yan Wang, Yawen Gao, Luis Puig, Matthias Augustin. Dermatol Ther (Heidelb) 2021
11